Home > The Oncopole > breadcrumb > The players

The players

Designed and built as a consistent cluster of competencies, the Oncopole hosts healthcare players, researchers, institutions, industrial partners, patients and families. Its objective: bringing together and mobilize all strengths and resources to fight the disease, work together and optimize the Prevention/Research/Healthcare continuum.

Caregivers, researchers, industrials: The innovation is underway!

Players...
In research... In healthcare ... In enhancement...
Public researchClinical researchSearch private The IUCT, the Cancer University Institute of Toulouse Oncopole Competitiveness Center, Toulouse Tech Transfer, the Projects Hotel and Pierre Potier Start-up Companies Incubator (Pépinières d’entreprises)
Research, in just one place, pools its resources to fight cancer. This unique concentration of strengths and resources contribute to understand the fundamental mechanisms of cancer, find new strategies for healthcare and research, and finally act by transferring therapeutic discoveries down to the bedside. The University Cancer Institute Oncopole is a new way to think cancer treatments. Besides the healthcare and public health missions of this establishment, another top priority: innovation and research for the benefit of patients. IUC Oncopole is place of healthcare, an international center for research as well as an innovation platform. The ultimate goal of Oncopole is to offer faster, more innovative healthcare for patients with cancer. Research improvement processes allows the implementation of the most promising projects, within the best regulatory framework.
Specific resources
Technical resources with enhanced effectiveness due to the proximity of multidisciplinary teams sharing platforms, maintenance and technical evolution. To accommodate : more than 300 beds and places.
To treat: 1200 healthcare professionals.
To operate: consulting rooms, operative units, diagnosis, therapeutic and technical platforms.
Complementary tools: the Grand Southwest Canceropole, transfer companies and project hotels have the financial, technical and human resources that facilitate encounters between key project stakeholders.
About training Institutional partners

Scientific and university training: the Toulouse PRES - 4 universities, 12 engineering schools, 300 teachers and researchers.

Vocational education and thematic or tailored training in oncology, open to all audiences: OncoResonance - the School of Cancer-related knowledge and specialties

The funding, construction, logistics and running of a site like Oncopole require support from regional, national and European partners: Initial financial support and convergence of public initiatives.

Running, structuring and supporting research 

Three measures contribute to the structuring, the running and the supporting of cancer research in Toulouse :

  • The RITC Foundation (Research and Innovation in Cancer Therapeutics),
  • The Toulouse Cancer Santé  Foundation
  • The Grand Southwest Canceropole

Even if these structures have different means of action and geographical boundaries, all three have the purpose and ambition to bring a continuous support to both fundamental and clinical research. Their objective: generate new advances in the knowledge of tumorigenesis mechanisms and in oncology healthcare. 

 

« This project, which brings together scientists, clinicians, academics, and industry around the fight against cancer is now in its operational phase and I am glad about that. The project will have an ambition that goes well beyond the site of the Oncopole but that will make it a regional reference and probably more. The challenge we face is to synergize all stakeholders in the fight against cancer in a process of innovation and progress. »

Monique Cavalier,  General Director of ARS Midi-Pyrénées

 

 

 

 

Testimony

« In this ambitious challenge of fighting cancer, we cannot succeed by ourselves. This fight requires a concentration of excellence. With this new model based on a willingness to gather strengths in behalf of a life sciences approach, we place the patient at the heart of research and research at the heart of the healthcare system.»

Benjamin GANDOUET,
Director of the Oncopole, life sciences and public health – Toulouse Métropole